The future of GU oncology is precision treatment. Lead the way with confidence.
Vesta Technology
Novel Biomarkers
Valar Labs' research team has developed and validated multiple unique Vesta biomarker models in over 1,000 patients using histology features.
Expertly Trained AI
Valar Labs' board-certified pathologists created 500,000+ annotations of tumors and their microenvironment to train our Computational Histology Artificial Intelligence (CHAI) platform, grounding the technology in biology.
Fast, H&E-Based Testing
Leveraging existing tumor specimens, first-of-its-kind AI analyzes pathology slides and returns actionable results in days for timely treatment decisions.